Instituto Oncologico Dr. Rosell IOR - Hospital Universitari Quiron Dexeus

Barcelona 8028

0 studies enrolling now · 1 studies all time

What they study most

Metastatic Melanoma, Unresectable Melanoma

Studies at this site

• IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18) — Running, not enrolling